P< 0.05 and in bold value indicates a
statistically significant difference.
* indicates significance compared to SHS-PWD NTN-PW
ǂ indicates significant compared to OHS-PWD NTN-PW
¥ indicates significant between SHS-PWLD EO-PE and OHS-PWLD EO-PE
‡ indicates significant between SHS-PWLD LO-PE and OHS-PWLD LO-PE
† indicates significant between SHS-PWLD NTN-PW and OHS-PWLD NTN-PW
Table 2: Maternal
levels of single biomarkers of OS and AGMs and their combination at
visit 1 (10-20 weeks, early 2nd trimester) and visit 2
(21-31 weeks, mid-pregnancy) among SHS and OHS pregnant women who later
developed PE